Elite Indiana Pharmacy
Jurisprudence Test Bank
(v10.0)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Testing "Hard Deck"
definitions, core statutes (IC 25-26), the 2026 SEA 293 licensure overhaul, and 8:1
technician ratios.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Simulation of compounding
variables, including Test & Treat (SB 221) standing orders, HEA 1568 contraceptive
prescribing, and Schedule II partial fill logic.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes, multi-variable failures
requiring the synthesis of emergency refills, Collaborative Practice Agreements (CPA),
and pharmacy closure protocols to avert regulatory sanctions.
PART I: THE PRIMER
Mastering the intricate, rapidly evolving landscape of Indiana Pharmacy Jurisprudence
transforms a competent pharmacist into an elite, legally impregnable healthcare provider. This
elite test bank bridges the gap between academic theory and real-world clinical application,
ensuring your mastery translates directly into elite professional competence under 2026/2027
standards.
The "Critical Axioms" Cheat Sheet
● The 2026 Licensure Overhaul (SEA 293): The MPJE is officially removed for licensure
and reciprocity in Indiana; pharmacists must pass the NAPLEX and complete a
Board-approved Indiana law continuing education curriculum.
● The 8:1 Ratio & Technician Autonomy: Pharmacist-to-technician ratios are expanded to
8:1 (maximum 3 trainees); technicians may perform remote data entry but absolutely
CANNOT perform final product verification.
● The "Test & Treat" Matrix (SB 221): Pharmacists operate under state standing orders to
test and treat COVID-19, Group B Strep, RSV, and Influenza, plus independently
prescribe immunizations (age 11+) and smoking cessation products.
● The 60-Day Terminal/LTCF CII Rule: Schedule II prescriptions cannot be refilled, but
partial fills are permitted up to 60 days from the issue date ONLY for patients with a
documented terminal illness or residing in a Long-Term Care Facility (LTCF).
● The 30-Day Emergency Refill Protocol: Pharmacists may grant a one-time emergency
, refill (max 30-day supply, once per 6 months) for non-controlled maintenance drugs if the
prescriber is unreachable, failure to dispense is seriously detrimental, and the prescription
was originally filled at that pharmacy.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: Under Indiana SEA 293 (Public Law 140-2026), an out-of-state pharmacist applies for
license reciprocity. Which action MUST the applicant successfully complete to achieve
licensure? A) Pass the Indiana MPJE and a compounding clinical exam. B) Submit to a 90-day
probationary supervision period under a Category I permit. C) Pass the NAPLEX and complete
the required Indiana pharmacy law continuing education curriculum. D) Pass the Uniform MPJE
(UMPJE) and the NAPLEX.
● The Answer: C (Pass the NAPLEX and complete the required Indiana pharmacy law
continuing education curriculum.)
● Distractor Analysis:
○ A is incorrect: SEA 293 explicitly removes the MPJE requirement for licensure.
○ B is incorrect: Probationary supervision is a disciplinary measure, not a reciprocity
standard.
○ D is incorrect: While the UMPJE launched in 2026, Indiana explicitly replaced the
state law exam with a CE mandate.
The Mentor's Analysis: Indiana's 2026 legislative shift focuses on continuing education over
standardized law testing to combat workforce shortages. Professional/Academic Intuition:
Reciprocity in 2026 requires CE law mastery, not the MPJE.
Q2: A community pharmacy intends to maximize its staffing models. Under current Indiana law,
what is the MAXIMUM allowed ratio of licensed pharmacy technicians to pharmacists on duty?
A) 4:1 B) 6:1 C) 8:1 D) 10:1
● The Answer: C (8:1)
● Distractor Analysis:
○ A is incorrect: 4:1 is an outdated ratio standard.
○ B is incorrect: 6:1 was the maximum prior to the recent expansion.
○ D is incorrect: Exceeding 8:1 is a direct violation of Indiana Board of Pharmacy
statutes.
The Mentor's Analysis: Ratio expansion empowers optimized care models, allowing pharmacists
to pivot to clinical services like Test & Treat. Professional/Academic Intuition: The hard deck for
technician ratios is strictly 8:1.
Q3: An institutional pharmacy dispenses drugs exclusively to inpatients and outpatients of the
connected hospital. Which pharmacy permit MUST this facility hold? A) Category I B) Category
II C) Category III D) Category IV
● The Answer: B (Category II)
● Distractor Analysis:
○ A is incorrect: Category I is for retail pharmacies serving the general public.
○ C is incorrect: Category III is for closed-door, central fill, or sterile compounding not
open to the public.
○ D is incorrect: Category IV does not exist in Indiana pharmacy jurisprudence.
The Mentor's Analysis: Permits dictate the operational boundaries of the facility. Category II is
, exclusively institutional. Professional/Academic Intuition: Retail is I, Institutional is II,
Closed-Door is III.
Q4: A pharmacist dispenses a generically equivalent drug instead of the prescribed brand-name
drug. According to IC 16-42-22, how MUST the substitution be identified on the prescription
label? A) "Substituted for" B) "[Generic Name] - Generic" C) "______ Generic for ______" D) "
Equivalency Dispensed"
● The Answer: C ("______ Generic for ______")
● Distractor Analysis:
○ A is incorrect: This syntax does not meet the strict statutory requirement.
○ B is incorrect: Fails to identify the brand name drug for which substitution was
made.
○ D is incorrect: Plausible novice assumption, but legally non-compliant.
The Mentor's Analysis: Generic substitution laws demand radical transparency to the patient
using exact statutory syntax. Professional/Academic Intuition: Labels must explicitly state
"Generic for".
Q5: A pharmacy technician receives a written prescription for a Schedule II controlled
substance. Which task is the technician strictly PROHIBITED from performing? A) Entering the
patient's demographic data into the system. B) Counting the medication and placing it in a vial.
C) Performing the final product verification before dispensing. D) Assisting with insurance
processing.
● The Answer: C (Performing the final product verification before dispensing.)
● Distractor Analysis:
○ A is incorrect: Data entry is a standard, legal technician duty.
○ B is incorrect: Technicians may physically prepare the drug.
○ D is incorrect: Technicians routinely handle third-party billing.
The Mentor's Analysis: Final product verification requires clinical judgment and absolute legal
accountability, which cannot be delegated. Professional/Academic Intuition: The pharmacist
alone owns the final verification.
Q6: A pharmacist delegates duties to pharmacy technicians in training within a Category I
pharmacy. What is the maximum number of trainees that can be supervised by one pharmacist
at any given time? A) 1 B) 3 C) 6 D) 8
● The Answer: B (3)
● Distractor Analysis:
○ A is incorrect: Too restrictive based on current code.
○ C is incorrect: This exceeds the limit for uncertified/unlicensed trainees.
○ D is incorrect: 8 is the total ratio limit, but not all can be trainees.
The Mentor's Analysis: The Board limits inexperienced trainees to prevent cognitive overload for
the pharmacist while maintaining the overall 8:1 efficiency. Professional/Academic Intuition: Max
3 trainees per 1 pharmacist.
Q7: A patient requests an emergency refill for their blood pressure medication on a Sunday. The
prescriber is unreachable. Under IC 25-26-13-25, what is the MAXIMUM days' supply the
pharmacist can dispense? A) 3-day supply B) 7-day supply C) 30-day supply D) 90-day supply
● The Answer: C (30-day supply)
● Distractor Analysis:
○ A is incorrect: This is a legacy rule from other jurisdictions; Indiana allows more.
○ B is incorrect: Plausible, but underestimates the statutory allowance.
○ D is incorrect: An emergency refill cannot exceed the lesser of the original fill or 30
days.
Jurisprudence Test Bank
(v10.0)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Testing "Hard Deck"
definitions, core statutes (IC 25-26), the 2026 SEA 293 licensure overhaul, and 8:1
technician ratios.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Simulation of compounding
variables, including Test & Treat (SB 221) standing orders, HEA 1568 contraceptive
prescribing, and Schedule II partial fill logic.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes, multi-variable failures
requiring the synthesis of emergency refills, Collaborative Practice Agreements (CPA),
and pharmacy closure protocols to avert regulatory sanctions.
PART I: THE PRIMER
Mastering the intricate, rapidly evolving landscape of Indiana Pharmacy Jurisprudence
transforms a competent pharmacist into an elite, legally impregnable healthcare provider. This
elite test bank bridges the gap between academic theory and real-world clinical application,
ensuring your mastery translates directly into elite professional competence under 2026/2027
standards.
The "Critical Axioms" Cheat Sheet
● The 2026 Licensure Overhaul (SEA 293): The MPJE is officially removed for licensure
and reciprocity in Indiana; pharmacists must pass the NAPLEX and complete a
Board-approved Indiana law continuing education curriculum.
● The 8:1 Ratio & Technician Autonomy: Pharmacist-to-technician ratios are expanded to
8:1 (maximum 3 trainees); technicians may perform remote data entry but absolutely
CANNOT perform final product verification.
● The "Test & Treat" Matrix (SB 221): Pharmacists operate under state standing orders to
test and treat COVID-19, Group B Strep, RSV, and Influenza, plus independently
prescribe immunizations (age 11+) and smoking cessation products.
● The 60-Day Terminal/LTCF CII Rule: Schedule II prescriptions cannot be refilled, but
partial fills are permitted up to 60 days from the issue date ONLY for patients with a
documented terminal illness or residing in a Long-Term Care Facility (LTCF).
● The 30-Day Emergency Refill Protocol: Pharmacists may grant a one-time emergency
, refill (max 30-day supply, once per 6 months) for non-controlled maintenance drugs if the
prescriber is unreachable, failure to dispense is seriously detrimental, and the prescription
was originally filled at that pharmacy.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: Under Indiana SEA 293 (Public Law 140-2026), an out-of-state pharmacist applies for
license reciprocity. Which action MUST the applicant successfully complete to achieve
licensure? A) Pass the Indiana MPJE and a compounding clinical exam. B) Submit to a 90-day
probationary supervision period under a Category I permit. C) Pass the NAPLEX and complete
the required Indiana pharmacy law continuing education curriculum. D) Pass the Uniform MPJE
(UMPJE) and the NAPLEX.
● The Answer: C (Pass the NAPLEX and complete the required Indiana pharmacy law
continuing education curriculum.)
● Distractor Analysis:
○ A is incorrect: SEA 293 explicitly removes the MPJE requirement for licensure.
○ B is incorrect: Probationary supervision is a disciplinary measure, not a reciprocity
standard.
○ D is incorrect: While the UMPJE launched in 2026, Indiana explicitly replaced the
state law exam with a CE mandate.
The Mentor's Analysis: Indiana's 2026 legislative shift focuses on continuing education over
standardized law testing to combat workforce shortages. Professional/Academic Intuition:
Reciprocity in 2026 requires CE law mastery, not the MPJE.
Q2: A community pharmacy intends to maximize its staffing models. Under current Indiana law,
what is the MAXIMUM allowed ratio of licensed pharmacy technicians to pharmacists on duty?
A) 4:1 B) 6:1 C) 8:1 D) 10:1
● The Answer: C (8:1)
● Distractor Analysis:
○ A is incorrect: 4:1 is an outdated ratio standard.
○ B is incorrect: 6:1 was the maximum prior to the recent expansion.
○ D is incorrect: Exceeding 8:1 is a direct violation of Indiana Board of Pharmacy
statutes.
The Mentor's Analysis: Ratio expansion empowers optimized care models, allowing pharmacists
to pivot to clinical services like Test & Treat. Professional/Academic Intuition: The hard deck for
technician ratios is strictly 8:1.
Q3: An institutional pharmacy dispenses drugs exclusively to inpatients and outpatients of the
connected hospital. Which pharmacy permit MUST this facility hold? A) Category I B) Category
II C) Category III D) Category IV
● The Answer: B (Category II)
● Distractor Analysis:
○ A is incorrect: Category I is for retail pharmacies serving the general public.
○ C is incorrect: Category III is for closed-door, central fill, or sterile compounding not
open to the public.
○ D is incorrect: Category IV does not exist in Indiana pharmacy jurisprudence.
The Mentor's Analysis: Permits dictate the operational boundaries of the facility. Category II is
, exclusively institutional. Professional/Academic Intuition: Retail is I, Institutional is II,
Closed-Door is III.
Q4: A pharmacist dispenses a generically equivalent drug instead of the prescribed brand-name
drug. According to IC 16-42-22, how MUST the substitution be identified on the prescription
label? A) "Substituted for" B) "[Generic Name] - Generic" C) "______ Generic for ______" D) "
Equivalency Dispensed"
● The Answer: C ("______ Generic for ______")
● Distractor Analysis:
○ A is incorrect: This syntax does not meet the strict statutory requirement.
○ B is incorrect: Fails to identify the brand name drug for which substitution was
made.
○ D is incorrect: Plausible novice assumption, but legally non-compliant.
The Mentor's Analysis: Generic substitution laws demand radical transparency to the patient
using exact statutory syntax. Professional/Academic Intuition: Labels must explicitly state
"Generic for".
Q5: A pharmacy technician receives a written prescription for a Schedule II controlled
substance. Which task is the technician strictly PROHIBITED from performing? A) Entering the
patient's demographic data into the system. B) Counting the medication and placing it in a vial.
C) Performing the final product verification before dispensing. D) Assisting with insurance
processing.
● The Answer: C (Performing the final product verification before dispensing.)
● Distractor Analysis:
○ A is incorrect: Data entry is a standard, legal technician duty.
○ B is incorrect: Technicians may physically prepare the drug.
○ D is incorrect: Technicians routinely handle third-party billing.
The Mentor's Analysis: Final product verification requires clinical judgment and absolute legal
accountability, which cannot be delegated. Professional/Academic Intuition: The pharmacist
alone owns the final verification.
Q6: A pharmacist delegates duties to pharmacy technicians in training within a Category I
pharmacy. What is the maximum number of trainees that can be supervised by one pharmacist
at any given time? A) 1 B) 3 C) 6 D) 8
● The Answer: B (3)
● Distractor Analysis:
○ A is incorrect: Too restrictive based on current code.
○ C is incorrect: This exceeds the limit for uncertified/unlicensed trainees.
○ D is incorrect: 8 is the total ratio limit, but not all can be trainees.
The Mentor's Analysis: The Board limits inexperienced trainees to prevent cognitive overload for
the pharmacist while maintaining the overall 8:1 efficiency. Professional/Academic Intuition: Max
3 trainees per 1 pharmacist.
Q7: A patient requests an emergency refill for their blood pressure medication on a Sunday. The
prescriber is unreachable. Under IC 25-26-13-25, what is the MAXIMUM days' supply the
pharmacist can dispense? A) 3-day supply B) 7-day supply C) 30-day supply D) 90-day supply
● The Answer: C (30-day supply)
● Distractor Analysis:
○ A is incorrect: This is a legacy rule from other jurisdictions; Indiana allows more.
○ B is incorrect: Plausible, but underestimates the statutory allowance.
○ D is incorrect: An emergency refill cannot exceed the lesser of the original fill or 30
days.
